BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11500509)

  • 21. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
    Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
    Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
    Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
    J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells.
    Wang W; Mariani FV; Harland RM; Luo K
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14394-9. PubMed ID: 11121043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.
    Hall JL; Wang X; Van Adamson ; Zhao Y; Gibbons GH
    Circ Res; 2001 Jun; 88(12):1247-53. PubMed ID: 11420300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha.
    Mukhopadhyay A; Shishodia S; Fu XY; Aggarwal BB
    J Cell Biochem; 2002; 84(4):803-15. PubMed ID: 11835405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
    Graham TR; Odero-Marah VA; Chung LW; Agrawal KC; Davis R; Abdel-Mageed AB
    Prostate; 2009 Feb; 69(2):168-80. PubMed ID: 18942118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
    Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
    J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.
    Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS
    Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.
    Aoki H; Fujii M; Imamura T; Yagi K; Takehara K; Kato M; Miyazono K
    J Cell Sci; 2001 Apr; 114(Pt 8):1483-9. PubMed ID: 11282024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of bone morphogenetic proteins BMP-2 and BMP-4 and their related postreceptor signaling system (Smads) in distraction osteogenesis of the mandible.
    Farhadieh RD; Gianoutsos MP; Yu Y; Walsh WR
    J Craniofac Surg; 2004 Sep; 15(5):714-8. PubMed ID: 15346005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB.
    Eliseev RA; Schwarz EM; Zuscik MJ; O'Keefe RJ; Drissi H; Rosier RN
    Exp Cell Res; 2006 Jan; 312(1):40-50. PubMed ID: 16259979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
    Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
    Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
    Imamura R; Konaka K; Matsumoto N; Hasegawa M; Fukui M; Mukaida N; Kinoshita T; Suda T
    J Biol Chem; 2004 Nov; 279(45):46415-23. PubMed ID: 15337758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.